Guarding Against Cancer

Researchers from the University of Dundee have shown that a drug previously used to treat Type II diabetes could potentially be used to protect against cancer. A study carried out by Professors Grahame Hardie and Doreen Cantrell has shown that the drug phenformin protects mice against a type of cancer called T-cell lymphoma. It does this by switching on the protein AMPK, which was first...

Genome sequencing lab awarded international quality stamp

Edinburgh Genomics has received an accreditation to mark the quality of its genome sequencing services. The University of Edinburgh’s DNA sequencing facility has received an internationally-recognised accreditation to mark the quality of its genome analysis services. The facility, called Edinburgh Genomics, employs advanced technologies that can decode the entire genetic make-up of a human or any other species in a matter of days. The Edinburgh...

Heart stent failure could be solved by molecule discovery

Scientists at Heriot-Watt University have found a molecule that could be used to stop heart stents failing. Each year, thousands of people in the UK have stents permanently inserted into their arteries to open them up, keeping blood flowing and treating the underlying cause of coronary heart disease (CHD). For around five percent of patients, this process can damage the artery walls and cause inflammation,...

University team to develop life-saving treatments with support from Scottish Enterprise

The University of Aberdeen’s mycoBiologics team has made significant progress in developing treatments to help tackle the growing problems of deadly fungal infections and antibiotic resistance, after being awarded £400,000 from Scottish Enterprise’s High Growth Spin-out Programme (HGSP). The team, headed up by Principal Investigator Dr Fiona Rudkin, has been working since 2012 on developing tailor-made antifungal antibodies to treat serious fungal infections – currently...

Celgene and Exscientia Enter 3-year AI Drug Discovery Collaboration Focused on Accelerating Drug Discovery in Oncology and Autoimmunity

Exscientia, a world-leading Artificial Intelligence (AI)-driven drug discovery company, announced today that it has entered a three-year AI drug discovery partnership with leading biopharma company Celgene, including an initial $25 million upfront payment and eligibility to receive substantial milestones based on the clinical, regulatory and commercial success of the program. In addition, Exscientia is due to receive tiered royalties on net sales on any product...

Glasgow medical firm showcases the best of UK life sciences sector

Glasgow company achieves international success, as British Science Week (8-17 March) celebrates science, technology, engineering and maths (STEM) across the UK. This British Science Week, Glasgow-based company, Tissue Solutions Ltd, demonstrates why the UK is a world leader in life sciences and medical research. Founded in 2007, Tissue Solutions is a global virtual biobank providing fully consented human tissue and biomaterials to pharmaceutical and biotech...

Top